M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas comprising oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.
Metrics to compare | M12 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipM12PeersSector | |
---|---|---|---|---|
P/E Ratio | 18.3x | 13.3x | −0.6x | |
PEG Ratio | 0.11 | 0.09 | 0.00 | |
Price/Book | 2.8x | 1.0x | 2.6x | |
Price / LTM Sales | 0.9x | 0.3x | 3.2x | |
Upside (Analyst Target) | 70.2% | 10.6% | 49.4% | |
Fair Value Upside | Unlock | 21.5% | 7.8% | Unlock |